Screener
Ardelyx ARDX Product sales, net — Cost of Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Ardelyx’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437402-26-000044
| (in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other revenues(1) | 2,748 | 7,585 | 3,848 | 13,885 |
| Total revenues | 120,877 | 97,662 | 215,350 | 171,776 |
| Less | ||||
| Cost of product sales(2) | 3,689 | 3,245 | 6,564 | 5,585 |
| Other cost of revenue(3) | 2,070 | 9,158 | 4,006 | 19,121 |
| Research and development(4) | 23,195 | 13,251 | 40,781 | 24,586 |
| Selling(4) | 66,949 | 57,952 | 134,344 | 114,752 |
| General and administrative(4) | 22,083 | 16,764 | 45,399 | 34,701 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ardelyx's product sales, net — cost of sales?
- Ardelyx (ARDX) reported product sales, net — cost of sales of $3.69M in Q2 2026.
- How has Ardelyx's product sales, net — cost of sales changed year-over-year?
- Ardelyx's product sales, net — cost of sales increased by 13.7% year-over-year, from $3.25M to $3.69M.
- What does product sales, net — cost of sales mean?
- This metric represents the direct costs incurred to manufacture and deliver the pharmaceutical products sold during the reporting period. It includes expenses such as raw materials, manufacturing labor, and distribution costs directly attributable to product sales. Analyzing this figure provides insight into the company's gross margin efficiency and the scalability of its commercial operations.
Ask your AI about Ardelyx's product sales, net — cost of sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude